Inventor · disambiguated record
Christoph Gibson
Also filed as: GIBSON CHRISTOPH
10 granted patents·10 pending applications·78 citations·filing 1999–2023
86Inventor score
Files withPHARVARIS GMBH7JERINI AG3PHARVARIS NETHERLANDS B V3BIOMET DEUTSCHLAND GMBH2GIBSON CHRISTOPH2
Top patents by PatentIndex Score
20 records- 0184US11820756B2Bradykinin B2 receptor antagonistsPHARVARIS NETHERLANDS B V·Filed 2022·Granted Nov 21, 2023·1 cites·12 claims
- 0281US10836748B2Bradykinin B2 receptor antagonistsPHARVARIS NETHERLANDS B V·Filed 2020·Granted Nov 17, 2020·2 cites·20 claims
- 0379US6326403B1Diacylhydrazine derivatives as integrin inhibitorsMERCK PATENT GMBH·Filed 1999·Granted Dec 4, 2001·49 cites·19 claims
- 0476US11261173B2Bradykinin B2 receptor antagonistsPHARVARIS NETHERLANDS B V·Filed 2020·Granted Mar 1, 2022·1 cites·15 claims
- 0576US7655624B2Peptide and peptide mimetic conjugates with integrin-inhibitor propertiesBIOMET DEUTSCHLAND GMBH·Filed 2001·Granted Feb 2, 2010·12 cites·12 claims
- 0676US6649613B1Diacylhydrazine derivativesMERCK PATENT GMBH·Filed 2000·Granted Nov 18, 2003·11 cites·35 claims
- 0761US8410134B28-oxy-quinoline derivatives as bradykinin B2 receptor modulatorsGIBSON CHRISTOPH·Filed 2008·Granted Apr 2, 2013·1 cites·36 claims
- 0859US7276482B2Peptide and peptide mimetic derivatives with integrin-inhibitors properties IIBIOMET DEUTSCHLAND GMBH·Filed 2001·Granted Oct 2, 2007·1 cites·11 claims
- 0957US2025228782A1Solid extended-release composition comprising bradykinin b2-receptor antagonistsPHARVARIS GMBH·Filed 2023·Application pending·0 cites
- 1057US2025228781A1Solid composition comprising solubilised bradykinin b2-receptor antagonistsPHARVARIS GMBH·Filed 2023·Application pending·0 cites
- 1155US2025268887A1Therapeutic uses of bradykinin b2-receptor antagonistsPHARVARIS GMBH·Filed 2023·Application pending·0 cites
- 1254US2024350418A1Lipid-based composition for oral administration of bradykinin b2-receptor antagonistsPHARVARIS GMBH·Filed 2022·Application pending·0 cites
- 1354US2025145584A1Solid form of a bradykinin b2-receptor antagonistPHARVARIS GMBH·Filed 2022·Application pending·0 cites
- 1451US2024335569A1Fibroblast activation protein inhibitors and use thereof3 B Pharmaceuticals GmbH·Filed 2022·Application pending·0 cites
- 1550US2011065760A1Compounds for the inhibition of rotamases and use thereofJERINI AG·Filed 2009·Application pending·0 cites
- 1644US2008221039A1Kinin Antagonists For Treating Bladder DysfunctionGIBSON CHRISTOPH·Filed 2006·Application pending·0 cites
- 1741US12391681B2(R)-3-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)morpholine derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseasesPHARVARIS GMBH·Filed 2020·Granted Aug 19, 2025·0 cites·14 claims
- 1841US12312330B21-((S)-1-(3-chloro-5-fluoro-2-((4-(1h-pyrazol-1-yl)-2-methylquinolin-8-yloxy)methyl)phenyl)ethyl)-imidazolidine-2,4-dione derivatives and related compounds as bradykinin (BK) B2 receptor antagonist for treating skin diseasesPHARVARIS GMBH·Filed 2020·Granted May 27, 2025·0 cites·12 claims
- 1939US2007054904A1Phenol derivatives and their use as rotamase inhibitorsJERINI AG·Filed 2003·Application pending·0 cites
- 2035US2008194524A1Compounds For the Inhibition of Undesired Cell Proliferation and Use ThereofJERINI AG·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christoph Gibson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →